This leads to a lot of wasted money and lower efficacy of treatment
Furthermore, the use of antiviral drugs to treat ME/CFS has been unsuccessful (488), contradicting the hypothesis that ME/CFS could be caused by a clearance failure of the pathogenic microbe (99, 107)
Patients on GLP-1 drugs had a 23% lower rate of developing DME one to two years after initiation of treatment compared to control
While the results were encouraging, by the mid-1990s Holst and Carolyn Deacon, a physiologist at the University of Copenhagen, confirmed an earlier finding by Rolf Mentlein, Baptist Galllwitz and Wolfgang Schmidt based at the University of Kiel in Germany who had found in 1993 that GLP-1 did not last long in the body because it was broken down in minutes by dipeptidyl peptidase-IV (DPP-4), an enzyme found in numerous tissues and in the bloodstream (Mentlein, Galllwitz, Schmidt
Phelps et al
Eligibility generally follows standard clinical thresholds: adults with BMI 30 kg/m, or BMI 27 kg/m with at least one weightrelated comorbidity, are typical candidates after screening